Satoshi Serada

5.8k total citations
128 papers, 4.2k citations indexed

About

Satoshi Serada is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Satoshi Serada has authored 128 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Oncology, 49 papers in Molecular Biology and 28 papers in Immunology. Recurrent topics in Satoshi Serada's work include Clusterin in disease pathology (18 papers), Cytokine Signaling Pathways and Interactions (18 papers) and Glycosylation and Glycoproteins Research (9 papers). Satoshi Serada is often cited by papers focused on Clusterin in disease pathology (18 papers), Cytokine Signaling Pathways and Interactions (18 papers) and Glycosylation and Glycoproteins Research (9 papers). Satoshi Serada collaborates with scholars based in Japan, United States and United Kingdom. Satoshi Serada's co-authors include Tetsuji Naka, Minoru Fujimoto, Tomoharu Ohkawara, Tadamitsu Kishimoto, Fumitaka Terabe, Teppei Nishikawa, Shintaro Nomura, Barry Ripley, Tsuyoshi Takahashi and Akihiro Kimura and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Satoshi Serada

124 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Satoshi Serada Japan 38 1.4k 1.3k 1.2k 524 431 128 4.2k
Zongbing You United States 35 1.7k 1.2× 1.5k 1.2× 1.5k 1.3× 295 0.6× 546 1.3× 87 4.3k
Claudia Wickenhauser Germany 37 1.4k 1.0× 1.1k 0.9× 1.1k 0.9× 433 0.8× 338 0.8× 199 4.3k
Mahmoud R. Hussein Egypt 35 1.2k 0.8× 978 0.8× 673 0.6× 456 0.9× 235 0.5× 146 4.1k
Atsushi Otsuka Japan 37 1.0k 0.7× 1.5k 1.2× 2.0k 1.7× 365 0.7× 353 0.8× 105 5.0k
John T. Seykora United States 35 2.2k 1.6× 1.3k 1.0× 708 0.6× 633 1.2× 230 0.5× 108 4.8k
Hideo Harigae Japan 35 2.0k 1.4× 679 0.5× 1.1k 0.9× 327 0.6× 492 1.1× 316 4.7k
Ling Wu China 31 2.2k 1.5× 1.3k 1.0× 1.5k 1.3× 272 0.5× 391 0.9× 74 4.9k
Alexei Gratchev Germany 39 2.7k 1.9× 1.0k 0.8× 2.0k 1.7× 459 0.9× 374 0.9× 123 5.4k
Kiichiro Tsuchiya Japan 35 1.7k 1.2× 1.2k 0.9× 1.0k 0.9× 446 0.9× 195 0.5× 150 4.2k
Jian Hong China 38 1.3k 0.9× 841 0.7× 1.5k 1.3× 453 0.9× 195 0.5× 120 3.9k

Countries citing papers authored by Satoshi Serada

Since Specialization
Citations

This map shows the geographic impact of Satoshi Serada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Serada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Serada more than expected).

Fields of papers citing papers by Satoshi Serada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Serada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Serada. The network helps show where Satoshi Serada may publish in the future.

Co-authorship network of co-authors of Satoshi Serada

This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Serada. A scholar is included among the top collaborators of Satoshi Serada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Serada. Satoshi Serada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ikenaga, Naoki, Tsuyoshi Takahashi, Koji Tanaka, et al.. (2025). Overexpression of Transferrin Receptor in Esophageal Squamous Cell Cancer Suggests Poor Prognosis and Potential Therapy. Cancer Science. 117(2). 393–406.
2.
Fujimoto, Minoru, Hayato Urushima, Yuji Suzuki, et al.. (2025). A Role for Leucine-Rich α2-Glycoprotein in Leukocyte Trafficking and Mucosal Inflammation in Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 31(6). 1637–1648.
3.
Takahashi, Tsuyoshi, Koji Tanaka, Kazuyoshi Yamamoto, et al.. (2024). Lipolysis-stimulated lipoprotein receptor promote lipid uptake and fatty acid oxidation in gastric cancer. Gastric Cancer. 27(6). 1258–1272. 5 indexed citations
4.
Hasan, Arif Ul, et al.. (2024). KDM4B Histone Demethylase Inhibition Attenuates Tumorigenicity of Malignant Melanoma Cells by Overriding the p53‐Mediated Tumor Suppressor Pathway. Journal of Cellular Biochemistry. 126(1). e30643–e30643. 2 indexed citations
5.
Serada, Satoshi, Minoru Fujimoto, Tomoharu Ohkawara, et al.. (2021). Gene therapy with SOCS1 induces potent preclinical antitumor activities in oral squamous cell carcinoma. Journal of Oral Pathology and Medicine. 51(2). 126–133. 6 indexed citations
6.
Nakajima, Hideki, Kimiko Nakajima, Mikiro Takaishi, et al.. (2021). The Skin–Liver Axis Modulates the Psoriasiform Phenotype and Involves Leucine-Rich α-2 Glycoprotein. The Journal of Immunology. 206(7). 1469–1477. 8 indexed citations
7.
Matsuzaki, Shinya, Satoshi Serada, Koji Matsuo, et al.. (2021). CD70 antibody‐drug conjugate: A potential novel therapeutic agent for ovarian cancer. Cancer Science. 112(9). 3655–3668. 13 indexed citations
8.
Serada, Satoshi, Tsuyoshi Takahashi, Takashi Matsunaga, et al.. (2021). Anti-Glypican-1 Antibody–drug Conjugate as Potential Therapy Against Tumor Cells and Tumor Vasculature for Glypican-1–Positive Cholangiocarcinoma. Molecular Cancer Therapeutics. 20(9). 1713–1722. 15 indexed citations
9.
Kato, Daiki, Tomonori Yaguchi, Takashi Iwata, et al.. (2020). GPC1 specific CAR-T cells eradicate established solid tumor without adverse effects and synergize with anti-PD-1 Ab. eLife. 9. 47 indexed citations
10.
Kitagawa, Koichi, Yuka Fukui, Hiroki Saito, et al.. (2019). Overexpression of SOCS3 mediated by adenovirus vector in mouse and human castration-resistant prostate cancer cells increases the sensitivity to NK cells in vitro and in vivo. Cancer Gene Therapy. 26(11-12). 388–399. 16 indexed citations
11.
Serada, Satoshi, et al.. (2019). Myosin heavy chain, a novel allergen for fish allergy in patients with atopic dermatitis. British Journal of Dermatology. 181(6). 1322–1324. 5 indexed citations
12.
Nakagawa, Satoshi, Satoshi Serada, Kosuke Hiramatsu, et al.. (2018). Intratumoral Delivery of an Adenoviral Vector Carrying the SOCS-1 Gene Enhances T-Cell–Mediated Antitumor Immunity By Suppressing PD-L1. Molecular Cancer Therapeutics. 17(9). 1941–1950. 8 indexed citations
13.
Sugase, Takahito, Tsuyoshi Takahashi, Satoshi Serada, et al.. (2017). SOCS1 Gene Therapy Improves Radiosensitivity and Enhances Irradiation-Induced DNA Damage in Esophageal Squamous Cell Carcinoma. Cancer Research. 77(24). 6975–6986. 37 indexed citations
14.
Hiramatsu, Kosuke, Satoshi Serada, Takayuki Enomoto, et al.. (2017). LSR Antibody Therapy Inhibits Ovarian Epithelial Tumor Growth by Inhibiting Lipid Uptake. Cancer Research. 78(2). 516–527. 33 indexed citations
15.
Hiramatsu, Kosuke, Kiyoshi Yoshino, Satoshi Serada, et al.. (2016). Similar protein expression profiles of ovarian and endometrial high-grade serous carcinomas. British Journal of Cancer. 114(5). 554–561. 21 indexed citations
16.
Umegaki‐Arao, Noriko, Katsuto Tamai, Keisuke Nimura, et al.. (2013). Karyopherin Alpha2 Is Essential for rRNA Transcription and Protein Synthesis in Proliferative Keratinocytes. PLoS ONE. 8(10). e76416–e76416. 9 indexed citations
17.
Ishii, Hiroshi, Shihori Tanabe, Masaki Ueno, et al.. (2013). ifn-γ-dependent secretion of IL-10 from Th1 cells and microglia/macrophages contributes to functional recovery after spinal cord injury. Cell Death and Disease. 4(7). e710–e710. 55 indexed citations
18.
Ohguro, Nobuyuki, Kei Nakai, Fumitaka Terabe, et al.. (2010). Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses. Experimental Eye Research. 91(2). 162–170. 82 indexed citations
19.
Terabe, Fumitaka, Minoru Fujimoto, Satoshi Serada, et al.. (2010). Comparative analysis of the effects of anti-IL-6 receptor mAb and anti-TNF mAb treatment on CD4+ T-cell responses in murine colitis. Inflammatory Bowel Diseases. 17(2). 491–502. 14 indexed citations
20.
Nishikawa, Teppei, Keisuke Hagihara, Satoshi Serada, et al.. (2008). Transcriptional Complex Formation of c-Fos, STAT3, and Hepatocyte NF-1α Is Essential for Cytokine-Driven C-Reactive Protein Gene Expression. The Journal of Immunology. 180(5). 3492–3501. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026